Ultrasound-guided dextrose injection treatment for chronic myofascial pain syndrome: A retrospective case series.
Journal
Journal of the Chinese Medical Association : JCMA
ISSN: 1728-7731
Titre abrégé: J Chin Med Assoc
Pays: Netherlands
ID NLM: 101174817
Informations de publication
Date de publication:
Sep 2020
Sep 2020
Historique:
pubmed:
30
4
2020
medline:
9
11
2021
entrez:
30
4
2020
Statut:
ppublish
Résumé
Due to the lack of an evidence-based consensus, managing refractory myofascial pain syndrome is challenging for clinicians. Dextrose injection (dextrose prolotherapy) emerged as a promising, cost-effective treatment. This study evaluated the efficacy of targeted ultrasound-guided dextrose injection for localized myofascial pain syndrome. We retrospectively reviewed the clinical outcomes of 45 patients with myofascial pain syndrome refractory to alternative treatments with targeted ultrasound-guided dextrose injection. Pretreatment symptom severity and symptomatic response 1 month after treatment were statistically analyzed using a visual analog scale (VAS)-based scoring system. Of 45 patients, 8 (24.4%) reported complete resolution of symptoms at the treated site. In total, 36 (80.0%) patients reported greater than 50% improvement in their symptoms. The mean pretreatment and posttreatment VAS scores were 7.0 and 2.44 (p < 0.001), indicating an overall 65.0% reduction in symptom severity. Targeted ultrasound-guided dextrose injection was remarkably effective for refractory localized myofascial pain syndrome, significantly reducing symptom intensities in the majority of treated patients within 1 month after a single injection.
Sections du résumé
BACKGROUND
BACKGROUND
Due to the lack of an evidence-based consensus, managing refractory myofascial pain syndrome is challenging for clinicians. Dextrose injection (dextrose prolotherapy) emerged as a promising, cost-effective treatment. This study evaluated the efficacy of targeted ultrasound-guided dextrose injection for localized myofascial pain syndrome.
METHODS
METHODS
We retrospectively reviewed the clinical outcomes of 45 patients with myofascial pain syndrome refractory to alternative treatments with targeted ultrasound-guided dextrose injection. Pretreatment symptom severity and symptomatic response 1 month after treatment were statistically analyzed using a visual analog scale (VAS)-based scoring system.
RESULTS
RESULTS
Of 45 patients, 8 (24.4%) reported complete resolution of symptoms at the treated site. In total, 36 (80.0%) patients reported greater than 50% improvement in their symptoms. The mean pretreatment and posttreatment VAS scores were 7.0 and 2.44 (p < 0.001), indicating an overall 65.0% reduction in symptom severity.
CONCLUSION
CONCLUSIONS
Targeted ultrasound-guided dextrose injection was remarkably effective for refractory localized myofascial pain syndrome, significantly reducing symptom intensities in the majority of treated patients within 1 month after a single injection.
Identifiants
pubmed: 32349034
doi: 10.1097/JCMA.0000000000000339
pmc: PMC7478217
pii: 02118582-202009000-00019
doi:
Substances chimiques
Glucose
IY9XDZ35W2
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
876-879Commentaires et corrections
Type : CommentIn
Références
Acupunct Electrother Res. 2001;26(4):229-38
pubmed: 11841108
PM R. 2011 Jun;3(6 Suppl 1):S78-81
pubmed: 21703585
Arch Phys Med Rehabil. 2001 Jul;82(7):986-92
pubmed: 11441390
J Am Board Fam Med. 2010 Sep-Oct;23(5):640-6
pubmed: 20823359
J Orthop Res. 2008 Jun;26(6):816-23
pubmed: 18240327
Clin Med Insights Arthritis Musculoskelet Disord. 2016 Jul 07;9:139-59
pubmed: 27429562
Am J Sports Med. 2008 Jul;36(7):1347-57
pubmed: 18310313
Arch Phys Med Rehabil. 2002 Mar;83(3 Suppl 1):S40-7, S48-9
pubmed: 11973695
J Pain Symptom Manage. 2010 Jan;39(1):116-25
pubmed: 19822404
Pain Ther. 2013 Jun;2(1):21-36
pubmed: 25135034
PM R. 2011 Oct;3(10):940-61
pubmed: 22024326
J Altern Complement Med. 2004 Aug;10(4):670-4
pubmed: 15353024